TABLE 1.
Summary of analyzed studies
| Author | Year | Sample size | Mean age (years) | Study design | Imaging | Statistical analysis | Main findings |
|---|---|---|---|---|---|---|---|
| Naghavi et al.26 | 2024 | 5,830 | 62 ± 10 | Prospective cohort study (MESA) | Non-contrast CAC scans enhanced by Al-enabled automated cardiac chamber volumetry and calcified plaque characterization |
| The AI–CAC model significantly improved the prediction of all CVD events (including HF, AF, and stroke) compared to the Agatston score alone. |
| Sakuragi et al.28 | 2016 | 487 | 69 ± 11 | Prospective cohort study | MDCT |
| Severe CAC is an independent determinant of high N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and a predictor of admission for HF in patients without a history of CAD or HF. |
| Ota et al.25 | 2022 | 550 | 72.5 ± 13.5 | Retrospective cohort study | Non-ECG-gated MDCT Invasive coronary angiography |
| Higher CAC score detected via non-contrast chest CT is significantly associated with all-cause mortality among patients with CHF. |
| Carr et al.21 | 2017 | 3,043 | 40.3 ± 3-6 | Prospective cohort study (CARDIA) | Non-contrast CT |
| In younger adults, a CAC score > 0 was associated with incident all CHD and all-cause death. |
| Kälsch et al.8 | 2010 | 4,230 | 59 ± 8 | Prospective cohort study (Heinz Nixdorf Recall Study) | EBCT |
| CAC is associated with the presence of CHF. This association is partially diminished after adjusting for traditional risk factors. |
| Haddad et al.17 | 2022 | 2,082 | 50.6 ± 17.0 | Prospective cohort study | Non-contrast CT |
| CAC score was independently associated with LV diastolic function. |
| de la Rosa et al.11 | 2025 | 6,667 | 62 ± 10 | Prospective cohort study (MESA) | Non-contrast CT EBCT |
| CAC score was a significant predictor of new-onset HFrEF. |
| Nitta et al.18 | 2019 | 157 | 71 ± 8 years for patients with CAC 66 ±13 years for patients without CAC | Retrospective cohort study | Non-contrast CT Gated SPECT for myocardial perfusion TTE |
| Log-transformed CAC score was significantly and independently associated with indices of impaired LV diastolic function (PFR and 1/3MFR). |
| Mhaimeed et al.10 | 2025 | 66,636 | 54.4 ± 10.6 | Retrospective cohort study | Non-contrast CT EBCT |
| A higher CAC score was associated with an increasing incidence of HF-related mortality in primary prevention patients. |
| Kitjanukit et al.29 | 2024 | 442 | 62.5 ± 10.4 | Retrospective cohort study | Non-contrast CT |
| Increasing CAC score categories were associated with a significantly increased HR for MACE. |
| Leening et al.5 | 2012 | 1,897 | 69.9 ± 6.5 | Prospective populationbased cohort study (The Rotterdam Study) | EBCT |
| CAC has a clear and graded association with the risk of developing HF in the elderly population, independent of traditional cardiovascular risk factors and incident overt CHD |
| Fathala et al.6 | 2019 | 204 | 48 ± 13 | Retrospective cohort study | Contrast CT ICA |
| The mean CAC score was significantly higher in the CAD HF group compared to the non-CAD HF group. |
| Choi et al.19 | 2025 | 15,193 | 55.8 ± 8.6 | Longitudinal cohort study | Non-contrast CT Echocardiography |
| CAC ≥ 100 significantly affects the progression of DD independently of other clinical factors. |
| Singh et al.30 | 2024 | 1,988 | DM cohort: 63.4 ± 8.9 Non-DM cohort: 60.3 ± 9.6 | Prospective cohort study | Contrast CT |
| Models leveraging radiomic features of calcium-omics and epicardial adipose tissue (fat-omics) extracted via deep learning from CTCS scans showed competitive or superior performance in predicting incident HF compared to traditional models. |
| Wakaki et al.22 | 2025 | 353 | 68.6 ± 12.7 | Retrospective cohort study | Non-ECG-gated CT ICA |
| The CAC score significantly predicted cardiovascular events (including CHF). |
| Hashimoto et al.23 | 2021 | 108 | 74 ±13 | Retrospective observational study | Non-contrast CT I-BMIPP SPECT |
| Increased CAC scores were associated with all-cause mortality in patients with CHF. |
| Tian et al.27 | 2025 | 1,310 | 56.5 ± 11.8 | Prospective cohort study (Chronic Renal Insufficiency Cohort) |
| Progression of CAC is associated with a higher risk of atherosclerotic CVD and all-cause mortality, but not with CHF. | |
| Ahmad et at.15 | 2025 | 6,592 | 62 ± 10 | Prospective cohort study (MESA) | Non-contrast CT EBCT | Chi-squared test ANOVA Kruskal–Wallis test Kaplan–Meier plot and log-rank test Multivariable Cox proportional hazard models Proportional hazards assumption evaluated using Schoenfeld residuals and formal testing Benjamin-Hochberg (BH) adjusted p value. | The combination of elevated IL-6 and CAC > 0 was associated with a higher risk of HFrEF, showing significant additive and multiplicative interactions. There was an antagonistic interaction for HFpEF. |
| Wada et al.20 | 2023 | 982 | 64.7 ± 6.6 | Prospective cohort study (NADESICO) | Non-contrast CT | Univariable and multivariable analysis Cox proportional hazard models C-statistic analysis | Adding the CAC score to the conventional cardiovascular risk factors (Suita score) significantly improved the predictive ability for future MACE in Japanese patients. |
| Elnagar et al.31 | 2024 | 435 | 48.04 ± 7.19 (Group I: CAC <400)and 49·77 ± 7.15 (Group II: CAC >400). | Retrospective cohort study | Contrast CT | Independent sample t-test Chi-squared test Multivariate logistic regression analysis | CAC scores ≥ 400 predict MACE. |
| Sharma et al.12 | 2017 | 5,282 | 62 ± 10 | Prospective cohort study (MESA) | Non-contrast CT EBCT | Cox proportional hazard models Proportional hazard assumption Test for trend | The CAC score was positively associated with incident HFpEF risk in women, but not in men. |
| Abunassar et al.32 | 2011 | 4,394 | No prior HF/LV dysfunction: 51.7 ± 10.3 HF and abnormal EF: 58.8 ± 11.7 High-risk CAD: 62.1 ± 9.7 | Retrospective cohort study | Contrast CT | Wilcoxon rank-sum test Fisher’s exact test | CAC = 0 excludes ischemic cardiomyopathy in patients presenting with HF. |
| Lehmann et al.33 | 2018 | 3,281 | 58.7 ± 7·5 | Prospective cohort study (Heinz Nixdorf Recall study) | EBCT | Chi-squared test Mann-Whitney U test Univariate and multivariable logistic regression Multivariable Cox proportional hazards regression Net reclassification index Integrated discrimination index | The CAC score is associated with CHF in persons without clinically overt CAD, but in longitudinal progression analysis, the predictive value of CAC progression has reduced risk prediction for CVDE when compared to the most recent CAC value. |